David Jin

Barings? investment decisions across all asset classes incorporate a comprehensive analysis that uses or combines top-down and/or bottom-up approaches to investment analysis. The firm utilizes economic, fundamental, technical/cyclical, and quantitative analyses, along with a sound understanding of both macro drivers and micro considerations in its investment decision-making process and to manage risk. They invest in a variety of fixed income and financing instruments across various industries as well as credit qualities and maturities in North America, Europe, Latin America, Africa/Middle East, and the Asia-Pacific region. Barings manages portfolios of public equity securities and equity-related securities of issuers of all sizes. The firm has teams focused on three alternative investment sectors: Real Estate, Private Equity & Real Assets, and Funds & Co-Investments.

Manufactures and markets pharmaceutical and biotechnology products

Functions as a College/University

Provides investment banking services

Operates as a clinical and commercial stage biopharmaceutical company that develops treatments for cancer, infectious disease and pain

Operates as a pharmaceutical company which develops and commercializes therapies for neurological diseases

Operates as a clinical stage company that develops novel immunotherapies for the prevention and treatment of cancer and infectious disease

Operates as clinical-stage biopharmaceutical company which develops novel immunotherapy''s

Operates as a biotechnology company that develops novel therapies for the treatment of Menkes disease and related copper metabolism disorders